Innovative Transgenics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 21 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Revenue 23.52%
(FY 2022)
- Profit 14.71%
(FY 2022)
- Ebitda 78.29%
(FY 2022)
- Net Worth 8.31%
(FY 2022)
- Total Assets 1.60%
(FY 2022)
About Innovative Transgenics
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Thobhanbhai Dholaria, Ashokbhai Gadhia, and Jitendra Kamani serve as directors at the Company.
- CIN/LLPIN
U01119GJ2003PTC043378
- Company No.
043378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Innovative Transgenics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thobhanbhai Dholaria  | Managing Director | 22-Dec-2003 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashokbhai Gadhia | Director | 05-May-2010 | Current |
| Jitendra Kamani | Director | 20-Nov-2012 | Current |
Financial Performance of Innovative Transgenics.
Innovative Transgenics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.52% increase. The company also saw a substantial improvement in profitability, with a 14.71% increase in profit. The company's net worth moved up by a moderate rise of 8.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovative Transgenics?
In 2020, Innovative Transgenics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Solar Agrotech Pvt LtdActive 30 years 8 monthsThobhanbhai Dholaria and Jitendra Kamani are mutual person
Cistronics Technovations Private LimitedActive 15 years 9 daysThobhanbhai Dholaria is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innovative Transgenics?
Unlock and access historical data on people associated with Innovative Transgenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovative Transgenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovative Transgenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
